At a glance
ClinicalIndex Comparison RecordN/ACompleted· 808 enrolled
Drug / intervention
Routine clinical practiceother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Multi-center Cross-sectional Study on Treatment Patterns and Patient Characteristics in Rheumatoid Arthritis (RA) Patients Treated by Biological DMARDs in China
In Brief
An observational study evaluating Routine clinical practice for Rheumatoid Arthritis. Completed, enrolled 808 participants across 15 sites.
Detailed Summary
This observational study will describe the treatment patterns of usage of biological DMARDs in routine clinical practice and the demographics and RA disease characteristics in patients suffering from rheumatoid arthritis. Patients will be recruited and examined the same day when recruited. There will be no follow up visit or treatment period only one visit in this study.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsRheumatoid Arthritis
CountriesChina
Collaborators--
Timeline
N/ACompletedFinished
2014201520162017201820192020202120222023202420252026
Enrollment StartDec 2013
Primary CompletionAug 2014
First PostedOct 2015
TodayJul 2026
First PostedOct 29, 2015
Enrollment StartDec 31, 2013
Primary CompletionAug 31, 2014
TodayJul 2, 2026
Enrollment to primary: 8 monthsPosted 10.7 years ago
Interventions
Routine clinical practiceother